Control da Regulación Xénica en Enfermidades
Regulación Xénica
IRIA MARIA
GOMEZ TOURIÑO
Profesora contratada doutora
Publicacións nas que colabora con IRIA MARIA GOMEZ TOURIÑO (10)
2024
-
Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101
International Journal of Molecular Sciences
-
Improving colorectal cancer screening programs
World Journal of Gastroenterology, Vol. 30, Núm. 22, pp. 2849-2851
-
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
Drug Delivery and Translational Research
-
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy
Cancers, Vol. 16, Núm. 13
2022
-
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1
2019
-
Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401
2017
-
Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes
Archivum Immunologiae et Therapiae Experimentalis, Vol. 65, Núm. 4, pp. 275-284
2015
-
Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes
Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217
2011
-
Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells
Cellular Immunology, Vol. 271, Núm. 2, pp. 319-328
2010
-
Autoantibodies to glial fibrillary acid protein and S100β in diabetic patients
Diabetic Medicine, Vol. 27, Núm. 2, pp. 246-248